Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-19

Clinical Trial Update: Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating gemcitabine in combination with mistletoe extract for advanced solid tumors. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemzar (gemcitabine)
  • Mistletoe extract (Viscum album extract)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: TERMINATED